Purina (03/03/2021)
From Line
Clinician’s Brief Partner Webinars
Subject line(s)
Your CE Certificate
CB Partner Webinar
{{webinarsautomatedemailsthankyou::omeda}}
#EVENTTITLE#
{{webinarsautomatedemailsthankyou::round_table}}
Purina{reg}
{{webinarsautomatedemailsthankyou::client_only_logo}}
{{webinarsautomatedemailsthankyou::client_only_logo_self_hosted}}
{{webinarsautomatedemailsthankyou::client_only_logo_alt}}
{{webinarsautomatedemailsthankyou::client_only_logo_width}}
{{webinarsautomatedemailsthankyou::client_only_logo_custom_css}}
{{webinarsautomatedemailsthankyou::client_color}}
{{webinarsautomatedemailsthankyou::supported_by}}
We hope the information proves helpful in managing and treating feline CKD patients.
Management of CKD requires follow-up, troubleshooting, and careful monitoring in an effort to improve quality of life and potentially increase longevity.
Effective communication with the client is key to achieving the best success with CKD treatment plans. This is important to understanding why a particular treatment is recommended or if the client cannot afford or administer the recommended treatment.
There is no overwhelming consensus on protein intake for CKD patients, but there is consensus phosphorus should be controlled in order to slow the progression of disease. This can be accomplished by feeding a renal diet and, if necessary, adding phosphate binders.
Maintaining appetite is important in the management of CKD patients because a thin body condition may be a poor prognostic indicator. When assessing patient appetite, ask clients not only if their pet is eating but what they’re eating, what quantity, and in what environment. This, along with hydration status and other medical conditions, may help influence your decision on the use of an appetite stimulant.
Management of CKD should be tailored to each cat. Prioritizing therapies such as appetite stimulants, hydration supplements, subcutaneous fluids, and antiemetics should be based on potential benefits and ease of administration.
Download a printable PDF of these takeaways.
{{webinarsautomatedemailsthankyou::printable_pdf_url}}
Please note that a minimum of 50 minutes worth of attendance during the live event was required to receive your certificate. If you did not download your CE certificate during the event, click here to download your certificate.
If you did not meet the 50-minute minimum, please view the on-demand version here and complete a 5-question quiz to receive your certificate.
{{webinarsautomatedemailsthankyou::ce_certificate_url}}
#AUDIENCEURL#
true
Thank you for attending our webinar, "#EVENTTITLE#," sponsored by Purina{reg}.
Thank you for attending our webinar, "#EVENTTITLE#."
![]()
|
|
|
Dear #FIRSTNAME#,
|
|
Thank you for attending our webinar, "#EVENTTITLE#," sponsored by Purina{reg}. We hope the information proves helpful in managing and treating feline CKD patients.
Thank you for attending our webinar, "#EVENTTITLE#." We hope the information proves helpful in managing and treating feline CKD patients.
|
|
Below you will find the Top 5 Takeaways from the webinar.
|
|
|
Top 5 Takeaways
|
- Management of CKD requires follow-up, troubleshooting, and careful monitoring in an effort to improve quality of life and potentially increase longevity.
- Effective communication with the client is key to achieving the best success with CKD treatment plans. This is important to understanding why a particular treatment is recommended or if the client cannot afford or administer the recommended treatment.
- There is no overwhelming consensus on protein intake for CKD patients, but there is consensus phosphorus should be controlled in order to slow the progression of disease. This can be accomplished by feeding a renal diet and, if necessary, adding phosphate binders.
- Maintaining appetite is important in the management of CKD patients because a thin body condition may be a poor prognostic indicator. When assessing patient appetite, ask clients not only if their pet is eating but what they’re eating, what quantity, and in what environment. This, along with hydration status and other medical conditions, may help influence your decision on the use of an appetite stimulant.
- Management of CKD should be tailored to each cat. Prioritizing therapies such as appetite stimulants, hydration supplements, subcutaneous fluids, and antiemetics should be based on potential benefits and ease of administration.
|
|
Download a printable PDF of these takeaways.
|
|
|
Your CE Certificate
|
|
Please note that a minimum of 50 minutes worth of attendance during the live event was required to receive your certificate. If you did not download your CE certificate during the event, click here to download your certificate. If you did not meet the 50-minute minimum, please view the on-demand version here and complete a 5-question quiz to receive your certificate.
|
|
|
Feel free to pass this along to colleagues who may be interested.
|
|
If you would like to reference the on‑demand version of the event, click here.
|
|
Thanks again for attending,
|
|
The Clinician's Brief Team
|
|
The Purina{reg} Team
|
|
|
|
</head>
<body style="-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;margin:0;min-width:100%;padding:0;width:100%" data-bg-color="#E9EBF2" bgcolor="#E9EBF2">
Thank you for attending our webinar, "#EVENTTITLE#," sponsored by Purina{reg}.
Thank you for attending our webinar, "#EVENTTITLE#."
![]()
|
|
|
|
Dear #FIRSTNAME#,
|
|
Thank you for attending our webinar, "#EVENTTITLE#," sponsored by Purina{reg}. We hope the information proves helpful in managing and treating feline CKD patients.
Thank you for attending our webinar, "#EVENTTITLE#." We hope the information proves helpful in managing and treating feline CKD patients.
|
|
Below you will find the Top 5 Takeaways from the webinar.
|
|
|
Top 5 Takeaways
|
- Management of CKD requires follow-up, troubleshooting, and careful monitoring in an effort to improve quality of life and potentially increase longevity.
- Effective communication with the client is key to achieving the best success with CKD treatment plans. This is important to understanding why a particular treatment is recommended or if the client cannot afford or administer the recommended treatment.
- There is no overwhelming consensus on protein intake for CKD patients, but there is consensus phosphorus should be controlled in order to slow the progression of disease. This can be accomplished by feeding a renal diet and, if necessary, adding phosphate binders.
- Maintaining appetite is important in the management of CKD patients because a thin body condition may be a poor prognostic indicator. When assessing patient appetite, ask clients not only if their pet is eating but what they’re eating, what quantity, and in what environment. This, along with hydration status and other medical conditions, may help influence your decision on the use of an appetite stimulant.
- Management of CKD should be tailored to each cat. Prioritizing therapies such as appetite stimulants, hydration supplements, subcutaneous fluids, and antiemetics should be based on potential benefits and ease of administration.
|
|
Download a printable PDF of these takeaways.
|
|
|
Your CE Certificate
|
|
Please note that a minimum of 50 minutes worth of attendance during the live event was required to receive your certificate. If you did not download your CE certificate during the event, click here to download your certificate. If you did not meet the 50-minute minimum, please view the on-demand version here and complete a 5-question quiz to receive your certificate.
|
|
|
Feel free to pass this along to colleagues who may be interested.
|
|
If you would like to reference the on‑demand version of the event, click here.
|
|
Thanks again for attending,
|
|
The Clinician's Brief Team
|
|
The Purina{reg} Team
|
|
|
|
